Tirzee 2.5 mg/0.5 mL Pen – Tirzepatide Weekly Injectable
Tirzee 2.5 mg/0.5 mL Pen – Tirzepatide Weekly Injectable
Tirzee 2.5 mg/0.5 mL Pen – Tirzepatide Weekly Injectable
Description
Tirzee 2.5 mg/0.5 mL Pen – Advanced GLP‑1/GIP Agonist for Diabetes & Weight Management
The Tirzee 2.5 mg/0.5 mL pre‑filled pen contains tirzepatide, a dual‑action GIP and GLP‑1 receptor agonist indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus (as an adjunct to diet and exercise) and in combination with lifestyle changes to reduce excess body weight.
Administered once weekly by subcutaneous injection, the 2.5 mg starting dose is typically used to initiate therapy and minimise side effects, with possible escalation under medical supervision.


